cover of episode Intermediate Risk Pediatric Hodgkin Lymphoma: Early Response-Adapted Treatment Is Key

Intermediate Risk Pediatric Hodgkin Lymphoma: Early Response-Adapted Treatment Is Key

2014/11/25
logo of podcast Journal of Clinical Oncology (JCO) Podcast

Journal of Clinical Oncology (JCO) Podcast

Frequently requested episodes will be transcribed first

Shownotes Transcript

Tailoring treatment in intermediate-risk pediatric Hodgkin lymphoma is feasible using an early response-based assessment for the omission of radiotherapy.